CombiMatrix Migrates Miscarriage Analysis Microarray Testing to Newer Scanning Panel
February 09, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 09, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Corporation to Release 2015 Fourth Quarter and Full Year Financial Results on February 17, 2016
February 08, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 08, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) announces that it will release financial results for the three months and full year ended December 31, 2015...
CombiMatrix Study Published in Genetics in Medicine
February 01, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 01, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal and postnatal...
CombiMatrix Announces Commercial Launch of Microarray Testing for Stillbirth Analysis
January 28, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Jan. 28, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal, miscarriage...
New Data From Multi-Year Study of Pregnancy Loss Support Efficacy and Diagnostic Power of CombiMatrix’s Chromosomal Microarray Analysis
January 06, 2016 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal, miscarriage analysis...
CombiMatrix Announces Multicycle Offering for Pre-Implantation Genetic Screening and Improved Cost Efficiencies
December 16, 2015 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Dec. 16, 2015 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal, miscarriage...
CombiMatrix Highlights Two Recent Developments
December 11, 2015 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Dec. 11, 2015 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal, miscarriage analysis...
CombiMatrix's Array for Pre-Implantation Genetic Screening Granted Conditional Approval From New York State Department of Health
December 10, 2015 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Dec. 10, 2015 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal, miscarriage analysis...
CombiMatrix Corporation Reports Third Quarter 2015 Financial and Operating Results
November 04, 2015 16:05 ET
|
CombiMatrix Corporation
Growth in Revenue and Test Volumes Driven by Miscarriage Analysis and Pre-implantation Genetic Screening; Reports Narrowed Net Loss and Strong Cash Collections
Conference Call Begins Today at 4:30...
CombiMatrix Corporation to Release Third Quarter Financial Results on November 4, 2015
October 28, 2015 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Oct. 28, 2015 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) announces that it will release financial results for the quarter ended September 30, 2015 after market close on...